Wasman Jane 4
4 · SELLAS Life Sciences Group, Inc. · Filed Jun 2, 2025
Insider Transaction Report
Form 4
Wasman Jane
Director
Transactions
- Purchase
Common Stock
2025-05-30$1.69/sh+20,000$33,800→ 30,400 total
Footnotes (1)
- [F1]The shares were purchased in multiple transactions at a price of $1.69. The reporting person undertakes to provide SELLAS Life Sciences Group, Inc., any security holder of SELLAS Life Sciences Group, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at the price set forth in this footnote.